About the Registry
IO Registry Steering Committee
Chair: George Holland, MD
The Interventional Oncology (IO) registry is a web-based
registry designed to initially collect 30 day safety data from
multiple centers. Five sites performed user acceptance
testing in April 2008, and the registry was operational by May
2008. In less than three months, 117 cases were entered
from six active sites.
The IO Registry is a product of the contribution of more than
12 expert interventional radiologists and will ultimately expand
to other practitioners around the globe. Phase one of the
registry is a 30 day safety study of ablations
performed on tumors located in the lung, kidney, and bone.
Phase two of the registry will allow for long term follow up for
efficacy, additional anatomical areas of treatment, and
additional methods of treatment. In phase three measures of
quality of life, performance status, image archive, and
survival or outcomes analysis will be added.
The IO Registry data will enable large multimember studies to
be performed, which will help to ensure that practicing
interventional oncology is guided by high quality
evidenced based medicine. Currently, there are many gaps in
our ability to provide adequate data regarding interventional
oncology procedures to our patients and referring
clinicians. This is due in large part to a lack of an
organized system for data accrual. The production of a
registry under the SIR Foundation will enable us to follow the
model of other physician specialists such as cardiologists who
have used registries to better define and refine their treatments
as well as to generate standardized reports of safety, efficacy,
outcomes, resource utilization, and patterns of practice.
The IO registry will support physicians by serving as a tool
and shared resource. The goals of the registry are to
provide standardized collection of data for a variety of purposes
including, but not limited to, the following:
- Increased access to data for increased publications
amongst approved investigators
- Multi-center trials for safety, efficacy, outcomes,
quality of life studies, etc
- Evaluation of combined therapies
- Collecting and quantifying resource utilization
- Patterns of practice studies
- Quality Assurance
- Credentialing
- PQRI
- Evidenced based practices and education
- Reimbursement opportunities
- Standardized reporting
The IO Registry Steering Committee was formed in June 2008.
IO Registry Steering Committee
George Holland, MD - Chair
S. Nahum Goldberg, MD
Matt Callstrom, MD, PhD
Gary Dorfman, MD
Damian Dupuy, MD
Debra Gervais, MD
Peter Littrup, MD
Stephen Solomon, MD
IO Registry Task Forces
Site Recruitment and Relations, IRB and data agreements,
Auditing of sites
Societal Interactions, SIR/SIRF representation
Infrastructure, IT, Data Analysis
Industrial Relations
Scientific Coordinator
Third Party payer relations
Professional Organizations
Federal Agencies
RETURN TO LOGIN PAGE
|
 |